Voltar
Artigo Acesso aberto Produção Nacional
BIBTEX RIS

Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil

2021; Baishideng Publishing Group; Volume: 27; Issue: 2 Linguagem: Inglês

10.3748/wjg.v27.i2.208

ISSN

2219-2840

Autores

Cyrla Zaltman, Rogério Serafim Parra, Lígia Yukie Sassaki, Genoile Oliveira Santana, Maria de Lourdes Abreu Ferrari, Sender Jankiel Miszputen, Heda M B S Amarante, Roberto Luiz Kaiser, Cristina Flores, Wilson Roberto Catapani, José Miguel Luz Parente, Mauro Bafutto, Odery Ramos, Carolina D Gonçalves, Isabella Miranda Guimaraes, José Joaquim Ribeiro da Rocha, Marley Ribeiro Feitosa, Omar Féres, Rogério Saad-Hossne, Francisco Guilherme Cancela e Penna, Pedro Ferrari Sales Cunha, Tárcia N. Gomes, Rodrigo Bremer Nones, Mikaell Alexandre Gouvêa Faria, Mírian Perpétua Palha Dias Parente, Antônio Scafuto Scotton, Rosana Fusaro Caratin, Juliana Senra, Júlio Maria Fonseca Chebli,

Tópico(s)

Tuberculosis Research and Epidemiology

Resumo

Understanding the treatment landscape of inflammatory bowel diseases (IBD) is essential for improving disease management and patient outcomes. Brazil is the largest Latin American country, and it presents socioeconomic and health care differences across its geographical regions. This country has the highest increase in IBD incidence and prevalence in Latin America, but information about the clinical and treatment characteristics of IBD is scarce.

Referência(s)